absorption
Plant-based vs shellfish glucosamine: the absorption data and why the source matters
Last reviewed
Plant-fermented glucosamine and shellfish-derived glucosamine deliver the same molecule. What differs is the source material, allergen profile, manufacturing consistency, and compatibility with vegan diets. The clinical evidence for glucosamine in joint support applies to both sources because the molecule is identical, but label transparency about source is a basic requirement that many products still fail.
Key takeaways
- Same molecule, different source: glucosamine is glucosamine regardless of extraction route.
- Allergen profile differs sharply: shellfish-derived products carry protein residues; plant-fermented does not.
- Plant fermentation produces tighter batch consistency because the substrate is controlled (corn glucose vs variable marine material).
- Clinical evidence applies to both sources: the Reginster and Pavelka trials were run on glucosamine sulfate, which is pharmacologically identical across sources.
- Marine-derived heavy metal residues are a documented supply-chain concern; plant fermentation sidesteps that vector.
What glucosamine does in the joint
Glucosamine is an amino sugar. The body uses it to synthesize glycosaminoglycans (GAGs) and proteoglycans, the molecules that give cartilage its elasticity and compressive resistance. The body produces its own glucosamine, but dietary supplementation raises the available pool of building blocks, which supports cartilage matrix turnover under daily joint load.
The clinical evidence for oral glucosamine is strongest for glucosamine sulfate (not glucosamine hydrochloride) and for the 1500 mg daily dose used in the major long-term trials. Reginster 2001 in the Lancet and Pavelka 2002 in Archives of Internal Medicine both ran three-year double-blind placebo-controlled trials showing reduced radiographic joint-space narrowing and improved WOMAC scores on that dose.
Two manufacturing routes
The glucosamine sold in supplements comes from one of two processes.
Shellfish-derived is the older route. Crustacean exoskeletons (shrimp, crab, lobster) are a byproduct of the seafood industry. Chitin is extracted from the exoskeletons, then hydrolyzed and deacetylated to yield glucosamine. This is efficient and cheap, which is why it dominated the category for decades.
Plant-fermented (branded GlucosaGreen by the manufacturer Cargill) is the newer route. A non-animal substrate, typically corn glucose, is fermented by a controlled strain of Aspergillus niger. The fungus produces N-acetylglucosamine, which is then converted to glucosamine sulfate through controlled chemistry. The resulting molecule is chemically identical to shellfish-derived glucosamine, but the upstream material is fully non-animal.
Head-to-head comparison
| Parameter | Shellfish-derived | Plant-fermented (GlucosaGreen) |
|---|---|---|
| Source material | Crustacean exoskeletons | Corn glucose fermented by Aspergillus niger |
| Glucosamine molecule | Identical | Identical |
| Shellfish allergen risk | Present (protein residues documented) | None |
| Vegan / vegetarian compatible | No | Yes |
| Iodine sensitivity safe | Risk depends on residuals | No source of iodine exposure |
| Heavy metal profile | Dependent on marine source quality | Controlled substrate |
| Batch consistency | Variable with source | Tighter tolerances |
| Environmental impact | Linked to shellfish fishery cycles | Agricultural feedstock |
| Clinical evidence in OA | Reginster 2001, Pavelka 2002 (sulfate form) | Same evidence applies (same molecule) |
The shellfish allergen question
Shellfish allergy is one of the most common adult-onset food allergies, affecting an estimated 2% of US adults. The proteins responsible (tropomyosin and others) can be present as residues in shellfish-derived glucosamine. Most glucosamine manufacturers process to remove protein residues, but residual material has been documented in commercial products.
For individuals with diagnosed shellfish allergy, plant-fermented glucosamine removes the risk at the source. This is the single clearest case where source matters independently of the molecule.
Iodine sensitivity is a related but separate concern. Marine sources can carry iodine residues. For individuals on thyroid medication or with iodine-sensitive conditions, plant fermentation is the safer choice.
Absorption and plasma pharmacokinetics
Persiani 2005 in Osteoarthritis and Cartilage measured plasma glucosamine levels after oral dosing in humans. The study established that oral glucosamine sulfate reaches measurable plasma concentrations, with peak levels around 2 hours post-dose and a clearance half-life consistent with the known pharmacokinetics of amino sugars.
The key point for the plant-vs-shellfish question: absorption and plasma pharmacokinetics are determined by the molecule, not the source. Plant-fermented glucosamine sulfate and shellfish-derived glucosamine sulfate show equivalent pharmacokinetic profiles in comparative testing because they are the same compound.
The practical differences (allergen, consistency, vegan compatibility) are upstream of absorption. Once the molecule is in the gut, the body treats both the same way.
Why clinical evidence transfers across sources
A recurring question is whether the landmark glucosamine trials (Reginster 2001, Pavelka 2002) "apply" to plant-fermented glucosamine, since those trials were run on shellfish-derived material. The pharmacological answer is yes: the trials measured the effect of glucosamine sulfate as a molecule, and plant-fermented glucosamine delivers the identical molecule. No molecular or pharmacokinetic difference has been documented between the two sources that would change the clinical outcome.
What does change is the reliability of the supply. A plant-fermented process run on a controlled substrate produces tighter batch-to-batch consistency than a marine-extraction process run on variable raw material. This is why newer formulations lean toward plant-fermented.
Frequently asked
Is plant glucosamine as effective as shellfish glucosamine?
Yes. The molecule is identical, so the clinical effect in trials is equivalent. What differs is the allergen profile, source sustainability, and manufacturing consistency.
I'm allergic to shellfish. Will plant glucosamine cause a reaction?
Plant-fermented glucosamine contains no shellfish-derived material. It is produced by fermentation of corn glucose. For diagnosed shellfish allergies, the plant-fermented source removes the allergen at its origin. Always verify with the manufacturer's documentation and, if you have a severe allergy, discuss with your allergist before starting any new supplement.
Does plant glucosamine contain corn protein?
The fermentation process converts corn glucose (simple sugar) into glucosamine. The resulting material is purified, so residual corn protein is minimal to absent. For individuals with diagnosed corn allergy (rare), verify with the manufacturer's allergen documentation.
Is glucosamine hydrochloride the same as glucosamine sulfate?
Pharmacologically similar but clinically distinct. The major long-term OA trials used glucosamine sulfate. The sulfate counterion appears to matter for the structural signal observed at 3 years, possibly because sulfate itself contributes to GAG synthesis. Glucosamine hydrochloride (HCl) is often cheaper but has a thinner evidence base for structural outcomes.
How does Vyos handle this?
OsteoGuard uses plant-fermented glucosamine sulfate (GlucosaGreen by Cargill) at the dose range supported by the Reginster and Pavelka trials. See the full plant-glucosamine ingredient page for the formulation detail, or the OsteoGuard product page.
References
- Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001. PMID 11214127
- Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis. Archives of Internal Medicine. 2002. PMID 12390062
- Henrotin Y, Mobasheri A, Marty M. Is there any scientific evidence for the use of glucosamine in the management of osteoarthritis? Arthritis Research & Therapy. 2012. PMID 22293240
- Persiani S, Roda E, Rovati LC, et al. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses. Osteoarthritis and Cartilage. 2005. PMID 16168682
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician if you have a diagnosed shellfish allergy, are pregnant, nursing, or taking prescription medication.